WVE
Wave Life Sciences Ltd.

2,430
Mkt Cap
$1.12B
Volume
2.32M
52W High
$16.38
52W Low
$5.28
PE Ratio
-9.47
WVE Fundamentals
Price
$7.08
Prev Close
$6.67
Open
$6.54
50D MA
$7.41
Beta
1.38
Avg. Volume
3.19M
EPS (Annual)
-$0.7015
P/B
9.11
Rev/Employee
$376,048.61
Loading...
Loading...
News
all
press releases
B. Riley Has Bearish Forecast for WVE FY2029 Earnings
WAVE Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Equities researchers at B. Riley reduced their FY2029 earnings per share (EPS) estimates for shares of WAVE Life Sciences in a note issued to...
MarketBeat·15h ago
News Placeholder
More News
News Placeholder
FY2026 Earnings Forecast for WVE Issued By Cantor Fitzgerald
WAVE Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Analysts at Cantor Fitzgerald boosted their FY2026 EPS estimates for shares of WAVE Life Sciences in a research note issued to investors on...
MarketBeat·15h ago
News Placeholder
What is HC Wainwright's Estimate for WVE FY2025 Earnings?
WAVE Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Equities research analysts at HC Wainwright lowered their FY2025 earnings estimates for WAVE Life Sciences in a report released on Tuesday...
MarketBeat·19h ago
News Placeholder
Wedbush Research Analysts Cut Earnings Estimates for WVE
WAVE Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Wedbush lowered their FY2025 earnings per share (EPS) estimates for WAVE Life Sciences in a research report issued on Monday, November 10th...
MarketBeat·19h ago
News Placeholder
Leerink Partnrs Has Pessimistic View of WVE FY2025 Earnings
WAVE Life Sciences Ltd. (NASDAQ:WVE - Free Report) - Equities researchers at Leerink Partnrs reduced their FY2025 earnings estimates for shares of WAVE Life Sciences in a research report issued on...
MarketBeat·19h ago
News Placeholder
WAVE Life Sciences (NASDAQ:WVE) Given New $20.00 Price Target at Wedbush
Wedbush upped their price target on shares of WAVE Life Sciences from $18.00 to $20.00 and gave the company an "outperform" rating in a research note on Tuesday...
MarketBeat·3d ago
News Placeholder
Wells Fargo & Company Has Lowered Expectations for WAVE Life Sciences (NASDAQ:WVE) Stock Price
Wells Fargo & Company lowered their price objective on shares of WAVE Life Sciences from $18.00 to $16.00 and set an "overweight" rating for the company in a research note on Tuesday...
MarketBeat·3d ago
News Placeholder
WAVE Life Sciences (NASDAQ:WVE) Shares Down 6.9% on Disappointing Earnings
WAVE Life Sciences (NASDAQ:WVE) Stock Price Down 6.9% After Earnings Miss...
MarketBeat·4d ago
News Placeholder
WAVE Life Sciences (NASDAQ:WVE) Announces Quarterly Earnings Results
WAVE Life Sciences (NASDAQ:WVE - Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.32) EPS for the quarter, missing the consensus estimate of ($0.30) by ($0.02...
MarketBeat·4d ago
News Placeholder
Wave Life Sciences (WVE) Reports Q3 Loss, Misses Revenue Estimates
Wave Life Sciences (WVE) delivered earnings and revenue surprises of -6.67% and -41.25%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5d ago

Latest WVE News

View

Advertisement|Remove ads.

Advertisement|Remove ads.